GC Biopharma signs ₩142.1bn Brazil export supply contract

GC Biopharma · KOSPI · 006280 · Nov 2, 2026 · Supply contracts

GC Biopharma filed a Brazil export supply contract with BLAU Farmaceutica S.A. worth ₩142.1bn, reported as 8.3% of revenue. The contract period runs from Jun 30, 2023 to Jun 29, 2028.

Key facts

Contract nameBrazil export supply contract
CounterpartyBLAU Farmaceutica S.A.
Contract amount₩142.1bn
% of revenue (as reported)8.3%
Period startJun 30, 2023
Period endJun 29, 2028

Comparison

Amount as % of FY2025 revenue (calculated)7.1%
Revenue 2025₩2.0tn
Revenue 2024₩1.7tn
Revenue 2023₩1.6tn

Context

By our calculation, the contract amount is 7.1% of FY2025 revenue.

Key metrics

Supply contracts

Supply contracts, last 12 months₩59.2bn As of Nov 2, 2026 Source 1
Supply contracts vs prior-year revenue3.0% As of Nov 2, 2026 Source 1
Contracts without a KRW amount0 contracts without a KRW amount excluded As of Nov 19, 2026

Related filings

Source: DART (Financial Supervisory Service) · Original filing on DART ↗ (opens the Financial Supervisory Service's DART site)